U.S. Household Products Stock News

Q3 2025 earnings beat sparks fresh interest in Globant Globant (GLOB) is back on investor radars after Q3 2025 results came in slightly ahead of guidance, highlighting steady demand for its higher value digital transformation and AI focused services despite currency headwinds. See our latest analysis for Globant. Despite the earnings beat, Globant’s share price has had a tough year, with a 90 day share price return of 33.45% and a 1 year total shareholder return of 54.55% pointing to fading...

Installed Building Products recently reported fourth-quarter earnings per share of US$3.24, beating expectations while revealing a 9% sales decline in its residential segment and announcing a new US$500 million share repurchase program alongside higher dividends. Management also reduced near-term revenue guidance and cited severe winter weather as a key factor pressuring residential insulation demand, even as commercial activity and acquisition efforts provided a partial offset. Next, we’ll...

Chewy, Inc. has reported its fourth-quarter and full-year 2025 results, with quarterly sales of US$3,264.7 million and net income of US$39.2 million, alongside a completed share repurchase of 7,893,480 shares for US$250.95 million under its May 2024 buyback program. While annual sales grew to US$12,601.5 million, full-year net income fell to US$222.8 million, highlighting that margin pressure persisted even as the company returned capital through buybacks and saw earnings per share decrease...

In late March 2026, BioNTech SE paused a COVID-19 vaccine trial with Pfizer due to weak enrollment while also presenting updated lung cancer data at the European Lung Cancer Congress and World Vaccine Congress, highlighting progress across pumitamig, gotistobart, and HER3-targeted ADC candidate BNT326/YL202. The combination of a halted infectious disease study and encouraging lung cancer results underlines BioNTech’s ongoing shift from pandemic vaccines toward a broader oncology-focused...

If you are wondering whether QuidelOrtho's current share price reflects its underlying value, this article walks through the key numbers that investors tend to focus on before making a decision. QuidelOrtho last closed at US$15.88, with returns of 4.1% over the past week, a 23.8% decline over the past month, and year to date and 1 year returns of 44.8% and 44.0% declines respectively. The 3 year and 5 year returns sit at 82.5% and 87.5% declines. These moves come as investors reassess the...

Enterprise Products Partners recently presented at the World Chemical Forum 2026, while also reporting quarterly revenue and earnings that surpassed analyst expectations and prompted positive estimate revisions. What stands out is that analysts now see the partnership’s earnings outlook improving even as it continues to trade at a discount to peers, highlighting a perceived gap between fundamentals and valuation. With this strong earnings surprise and upgraded forecasts in mind, we’ll now...

If you are wondering whether Intuit's current share price lines up with its underlying worth, this breakdown is designed to help you frame that question clearly. The stock recently closed at US$417.36, with a 2.7% decline over 7 days, a 13.3% decline over 30 days, and a 33.7% decline year to date, while the 1 year return sits at a 24.5% decline. Recent attention around Intuit has largely focused on its position as a major software provider and how market sentiment toward technology names has...

Century Aluminum and Emirates Global Aluminium recently announced a joint venture to build a new primary aluminum smelter in Oklahoma, a project that would more than double current U.S. primary aluminum production against the backdrop of a new 50% tariff on imported steel and aluminum. This combination of a major domestic capacity build-out and tighter import conditions materially reshapes the landscape for U.S. aluminum producers, with Century Aluminum positioned at the center of a...

Amdocs recently extended its long-term relationship with T-Mobile under a new multi-year agreement covering managed services, software development, and AI innovation, while also expanding its engagement with Vodafone Germany, adding two western European clients, completing the Matrixx Software acquisition, and unveiling its telecom-focused aOS agentic operating system. Together, these moves point to Amdocs deepening its role at large carriers and broadening its telecom software capabilities...

MGIC Investment stock overview after recent performance shift MGIC Investment (MTG) has drawn attention after a recent mix of returns, with a 1 day gain of 1.9%, a month return of 1.9%, a past 3 months decline of 6.8%, and a year to date decline of 7.3%. See our latest analysis for MGIC Investment. The recent 1 day 1.9% share price gain, on a last close of $27.02, comes after weaker short term momentum, while multi year total shareholder returns above 100% point to a stock that has...

DigitalOcean Holdings is set to join the S&P MidCap 400 and leave the S&P SmallCap 600 on April 9, 2026, as part of S&P Dow Jones Indices’ routine index reshuffling. This index change can influence how much capital is allocated to DigitalOcean by index-tracking funds and may alter the stock’s trading profile. Next, we’ll examine how DigitalOcean’s move into the S&P MidCap 400 could influence its investment narrative around growth and risk. Uncover the next big thing with 32 elite penny...

Wondering if Gentex at around US$21.50 is genuinely good value or just looks cheap on the surface? This article walks through the key signals that matter for you. The stock has returned 0.5% over the last 7 days, while the 30 day and year to date returns of a 2.6% decline and a 9.2% decline contrast with a 1 year gain of 2.6%, and a 3 year and 5 year decline of 17.1% and 35.1%. Recent coverage has focused on how Gentex fits within the auto components space and what that means for sentiment...

Tradeweb Markets (TW) is drawing fresh attention after reporting record total trading volume of US$87t for March 2026, with higher average daily and first quarter volumes tied to volatility, client activity, and wider use of electronic tools like AiEX. See our latest analysis for Tradeweb Markets. The record trading volumes come as Tradeweb Markets' share price has risen 16.35% year to date and 11.60% over 90 days, while the 1 year total shareholder return is a 5.27% decline and the 3 year...

International Business Machines (IBM) stock is back in focus after a new collaboration with Arm to co-develop dual-architecture hardware designed to handle enterprise AI and data‑heavy workloads with greater flexibility and security. See our latest analysis for International Business Machines. All this AI, cloud, and quantum news comes as IBM’s share price sits at US$246.74, with a 7 day share price return of 4.0% but a 90 day share price return decline of 18.43%, while the 1 year total...

Wondering if Northern Trust at US$143.32 is still offering value after a strong run, or if you are turning up late to the story. The stock has returned 5.2% over the last 7 days, 3.4% over the last 30 days and 2.9% year to date, with a 71.8% return over 1 year, 79.7% over 3 years and 51.6% over 5 years. This naturally raises questions about what is already priced in. Recent coverage around Northern Trust has focused on how a prolonged period of strong returns can reshape expectations around...

Northrop Grumman recently supported NASA’s crewed Artemis II launch with its five‑segment solid rocket boosters and showcased its modular, autonomous Lumberjack drone in a U.S. Army exercise, underscoring its role across space and defense missions. These advances in crewed spaceflight hardware and expendable uncrewed systems highlight how Northrop Grumman is aligning its capabilities with evolving military and space‑exploration priorities. Now we’ll examine how Northrop Grumman’s Lumberjack...

Why recent ProPetro moves have investors paying closer attention ProPetro Holding (PUMP) has drawn fresh attention after its industrialized model and core completions business generated solid results and free cash flow, even as slower completions activity and tariff pressures weighed on the sector. At the same time, the growing role of the PROPWR platform in the overall business has added a new angle for investors. It highlights how ProPetro is balancing its legacy hydraulic fracturing...

In March 2026, Johnson & Johnson announced a US$500 million R&D co-funding agreement with Royalty Pharma across 2026 and 2027 to advance JNJ-4804, a novel co-antibody therapy targeting both IL-23 and TNF pathways in autoimmune diseases. This collaboration gives Royalty Pharma exposure to an early-stage, dual-pathway autoimmune candidate that could meaningfully influence the mix and risk profile of its royalty portfolio. Next, we’ll examine how this substantial R&D co-funding commitment...

Q4 earnings beat and analyst reactions Victoria's Secret (VSCO) has been in focus after fiscal Q4 and full-year 2025 results surpassed both revenue and profit guidance, with comparable sales growth in Q4 and the year leading to a new round of analyst rating updates. See our latest analysis for Victoria's Secret. Victoria's Secret shares have reacted strongly around the earnings news, with a 1-day share price return of 4.91% and 7-day return of 11.48%. However, the 90-day share price return of...

Nova (NasdaqGS:NVMI) is back on investor radars after years of growth in revenue and earnings per share, coupled with strong free cash flow margins that underline its position in semiconductor process control. See our latest analysis for Nova. Novoa’s recent share price momentum has been strong, with a 7 day share price return of 7.82% and a year to date share price return of 28.27%. The 1 year total shareholder return of 161.15% shows how powerfully sentiment has shifted over a longer...

In its fourth-quarter 2025 investor letter, TimesSquare Capital’s U.S. Small Cap Growth Strategy highlighted NewAmsterdam Pharma’s CETP inhibitor program for cardiovascular patients, citing strongly positive indications ahead of trial readouts. This attention underscores how emerging data around LDL-lowering CETP inhibitors can quickly elevate a smaller biopharma company’s profile within the cardiovascular treatment landscape. We’ll now examine how growing optimism around NewAmsterdam...

Netflix, ticker NasdaqGS:NFLX, has launched Netflix Playground, a global, ad free gaming app for children. The service is being rolled out across all membership tiers with no ads or in app purchases. The launch expands Netflix's offering beyond video streaming into interactive content aimed at young audiences. For investors watching NasdaqGS:NFLX, Netflix Playground marks a clear push deeper into family focused entertainment, not just passive viewing. Netflix already operates a large...

The United States market has experienced a notable upswing, climbing 4.4% in the last week and an impressive 32% over the past year, with earnings projected to grow by 16% annually. In this environment, identifying stocks that may be undervalued requires a keen eye for potential growth and resilience amidst broader market gains, as highlighted by companies like BillionToOne and others.

The market has climbed 4.4% in the last 7 days and is up 32% over the last 12 months, reflecting strong investor confidence. For those looking to invest in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value when backed by solid financial foundations. This article highlights several penny stocks that demonstrate financial strength and potential for long-term growth amidst current market conditions.